At Ó³»´«Ã½â€™s Center for the Development of Therapeutics, biologists collaborate with drug-development experts to bring novel therapies to the clinic.
Researchers find key biological factors associated with efficacy of the tuberculosis vaccine, and suggest ways to further study and monitor vaccine-induced immunity.
Researchers have boosted the efficiency of prime editing, a highly versatile CRISPR-based gene editing technology, and used the improved system to correct disease mutations in cells.
Made of components found in the human body, the programmable system is a step toward safer, targeted delivery of gene editing and other molecular therapeutics.